Physician profile
Chris E Chacko
NPI 1679731665
$7,485.60
in general payments reported to CMS, 2019-2025
14 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $2,265 · 2021: $328 · 2022: $925 · 2023: $2,022 · 2024: $148 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464 · Travel and Lodging: $1,176 · Gift: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.58 |
| Travel and Lodging | $1,175.86 |
| Gift | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,265.44 | 2019-2022 | |
| Smith+Nephew, INC. | $1,777.49 | 2019-2025 | Tula, Coblation, Halo |
| Aerin Medical INC. | $1,397.42 | 2020-2025 | |
| Medical Device Business Services, INC. | $858.49 | 2019 | |
| Inspire Medical Systems, INC. | $373.58 | 2019-2025 | Inspire |
| Acclarent, INC | $283.36 | 2019-2023 | Trudi Nav Cable |
| Medtronic, INC. | $277.77 | 2022-2023 | Pteye Parathyroid Detection System |
| Genzyme Corporation | $81.60 | 2024 | |
| Alk-Abello, INC | $62.24 | 2021 | |
| Boston Scientific Corporation | $36.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.37 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $21.00 | 2025 | |
| Intersect Ent, INC. | $16.38 | 2021 | |
| Merck Sharp & Dohme LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.